Kimberly-Clark Corporation (KMB)

Rating: HOLD

HOLD (5-tier) · income compounder · conviction: medium

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies -7% vs spot
• Monte Carlo median implies -18% vs spot
• DCF fair value implies -19% vs spot — but this is terminal-value sensitive (exit-multiple $93 vs Gordon $149, 60% apart), so it carries less weight
• Bear case (Structural — Private-Label / Brand Erosion) downside is -57% vs spot
• Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $109.77 and ~14.4x forward earnings, the market prices KMB as a mid-quality staple: durable but cyclically exposed, and cheaper than peers CL (23.6x) and CHD (26.0x) trading at similar ~4% growth and low-20s margins. The engine reads this as roughly fair, not cheap. Its base path assumes ~4% segment growth and an 18.9% margin, generating about $7.7 of earnings on 0.334bn diluted shares, held at a 14.7x multiple. That produces a probability-weighted target near $106, below spot, so the rating is HOLD. The gap to the peer-implied ~$171–179 is not a mispricing to arbitrage; it reflects KMB's weaker mix and heavier private-label exposure in tissue. The most damaging risk is the same one the discount already hints at: elevated FY2025 capex ($1.14bn versus a ~$0.72bn prior run-rate) compressing free cash flow while private-label share advances, so both earnings and the multiple de-rate together rather than the volume recovery the base case needs.

The dashboard below is the whole argument on one page: spot ($115) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The highest-probability bear mechanism is the base case failing downward into the recession path, not the structural tail. KMB's pricing engine has carried growth through the last cycle while volumes stayed soft. If input costs re-accelerate or retailers push promotional intensity, that pricing can no longer clear the cost curve: organic growth slips toward zero and adjusted margin drifts from 18.9% to ~17%. Earnings fall from ~$7.7 to ~$6.6, and a market that already applies a discount de-rates the multiple further toward the low teens. The dividend, near a 4.7% yield, then competes with a capex build that has not yet tapered, tightening cover and removing the buyback support that has flattered per-share figures. A ~$88 target is the credible landing zone.

Key Debate

P/E Multiple explains 57% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.43 vs analyst floor -0.01 → delta +0.44 (n=23 mgmt / 11 Q&A; 60th pctile across the S&P book, z +0.3).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1000 articles): avg ticker sentiment +0.12 (bullish 11% / bearish 3%)

Scenario Analysis

The tree runs from a structural 'Structural — Private-Label / Brand Erosion' downside ($49) to a 'Bull — Defensive Re-Rate' bull case ($168); the probability-weighted blend (PWEV $106) is -7% versus spot.

Scenario rationale — what each probability buys (the driver path behind every target):

• Structural — Private-Label / Brand Erosion (20%, $49). Structural impairment — private-label / brand erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 49.37; probability: 0.2.
• Consumer / Input Recession (18%, $88). Cyclical downturn — branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) weakens for 1–2 years before normalising. Drivers — implied_target: 87.72; probability: 0.18.
• Base — Pricing-Led Organic Growth (34%, $113). Mid-cycle — normalised branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail); disciplined capital allocation; steady returns. Drivers — implied_target: 113.5; probability: 0.34.
• Growth — Premium Innovation + EM (20%, $143). Upside — premium innovation + emerging markets lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 143.31; probability: 0.2.
• Bull — Defensive Re-Rate (8%, $168). Upside tail — sustained tight conditions or a structural re-rate on premium innovation + emerging markets. Drivers — implied_target: 168.55; probability: 0.08.

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $95 and 32% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (57% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 7.5%, 12x terminal FCF multiple → $93. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 23.58x) implies $179. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Across all anchors the spread is 81% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Consumer Staples — Household

This name sits in the Consumer Staples — Household as a household_personal. branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: PG (household_personal) · CL (household_personal) · KVUE (household_personal) · KMB (household_personal) · EL (household_personal) · CHD (household_personal) · CLX (household_personal)

Mapping note: name-level 'Structural — Private-Label / Brand Erosion' (20%) + 'Consumer / Input Recession' (18%) map to cluster Structural — Private-Label / Brand Erosion (38%); name-level 'Growth — Premium Innovation + EM' (20%) + 'Bull — Defensive Re-Rate' (8%) map to cluster Upside — Premium Innovation / EM (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Structural — Private-Label / Brand Erosion () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_household cycle is the shared macro driver. Driver — branded HPC pricing power + organic volume + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 7.5% · Σ PV(FCF) $11B + PV(terminal) $26B = EV $38B; + net cash → equity $31B ÷ diluted shares 0.33B = $93/share (exit-multiple terminal).

• Gordon (perpetuity-growth) terminal at 2.5% → $149/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 12% vs WACC 8% → above WACC — the build is value-creative.

Peer set

Peer-median fwd P/E → $179; EV/Rev → $170.

Weighted fair-value math

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Household & Personal Care multiple (AI re-rating) (base 14x)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0.8% of revenue; cash conversion (OCF/NI) 136% — cash-backed.

Catalyst Calendar

• 2026-03-19 (~-111d) — 2025 restructuring/'Powering Care' programme completion + margin-target update (authored)
• 2026-06-09 (~-29d) — International Family/Professional segment reorganisation / potential divestiture update (authored)
• 2026-08-07 (~30d) — Quarterly earnings — est. EPS $1.99 (AV EARNINGS_CALENDAR)
• 2026-11-10 (~125d) — FY2027 organic-growth + capital-allocation guidance (authored)

Forecast Track Record

• EPS surprise: beat 87.5% of the last 8 quarters; average surprise +5.9%.

Competitive Moat

Narrow moat. KMB's brand equity in tissue/personal care is a narrow moat under private-label pressure; the falsifiable claim is that its discount to CL (~23.6x) and CHD (~26.0x) is earned, not a mispricing - if private-label unit share rises more than ~2pp/yr in its core aisles, the moat is failing and the ~14.7x multiple should compress toward the low-teens/value-trap floor rather than close the peer gap.

Moat sources:

• Leading brands in tissue (Kleenex, Cottonelle, Scott) and personal care (Huggies, Kotex) with global distribution scale
• Retail scale and category-management relationships that hold shelf space, though tissue is one of the most private-label-penetrated aisles
• Emerging-market distribution footprint (diapers/feminine care) as a genuine growth/mix lever the US business lacks
• NO durable pricing-power moat in commoditised tissue; pricing power is stronger in personal care than in the paper-based categories

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

What the Market Is Pricing In

At the current price, the market pays 15.2× forward EPS, vs the house DCF terminal 12.0×, and a peer median 23.58×. The house DCF sits 19% below spot, so the market is pricing in more than the house case — roughly 1.9pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Peer Quality & Weighting

Quality-weighted forward P/E: 19.1× (simple median 23.58×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $91–$131, centre $109 (-5% vs spot); spot sits at the 59th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Defensive Re-Rate): $168.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (34.0); Revenue CAGR ±3pp (28.0); Terminal × ±15% (24.0); WACC ±1pp (9.0); Capex intensity ±15% (9.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Source Log

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 12×, FY+5 revenue $20B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic sales growth (y/y) < 0.015 (2 consecutive prints → staples_household — branded HPC pricing power + organic volume). Base assumes ~4% segment growth; a slide toward the recession path (−1% to +1.5%) signals pricing power is failing to offset volume and mix. The midpoint between Base (4%) and the Recession driver (−1%) is ~1.5%.
• Adjusted operating margin < 0.18 (2 consecutive prints → staples_household — input costs and promotional intensity). Base margin is 18.9%; the recession path assumes 17%. A sustained print below 18% indicates input-cost or promotional pressure the pricing engine is not clearing, moving the name toward the cyclical case.
• Private-label unit share in core categories (tissue/personal care) > 0.02 (2 consecutive prints → staples_household — downside: private-label / brand erosion). A rising private-label share gain of more than ~2pp y/y in KMB's core aisles is the observable marker of the structural-impairment scenario, where both volume and the multiple de-rate.
• Free cash flow (operating cash flow − capex), annual < 1.7 (2 consecutive prints → staples_household — capital intensity & shareholder returns). FY2025 FCF was ~$1.64B (OCF $2.78B − capex $1.14B), depressed by the peak capex build. If FCF stays below ~$1.7B once the build tapers, the capex glidepath in the model is too optimistic and dividend cover tightens against the ~$1.66B payout.
• Trailing capex ($B, annual) > 1.05 (single event → staples_household — capital intensity & shareholder returns). The model assumes capex tapers from the ~$1.14B FY2025 peak back toward maintenance. A second consecutive year above ~$1.05B would break the D&A-lags-capex bridge and signal a structurally higher capital-intensity regime than 3% of revenue.

Fact / Inference / Speculation

• FACT: Spot $115; 52-week range $91–$131; engine rating HOLD; base-case target $106 (-7%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
• INFERENCE: Triangulated FV $98 (-15% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Recommendation: HOLD

Balanced: triangulated fair value $107 (-6% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

• No suitability assessment has been performed for any individual.
• Market data may be delayed or inaccurate; figures are as of the analysis date.
• Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
• Forecasts are uncertain; past performance is not indicative of future returns.
• The author or publisher may hold positions in securities mentioned.
• Users should verify information against primary sources (company filings) before acting.
• Investing involves risk of loss; there is no guarantee any target price is achieved.
• Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.